Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-09-11T02:44:41.735Z.
Calculation as of: 2026-09-11T02:44:41.735Z.
Quote observation: 2026-09-10T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d670d92a9ed985c4ba88d5830250f1e4eb43691fb1e0723b4e8904464d1c2daf
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$10.45B
EV/EBITDA Ratio
20.31x
TTM Avg
9.46x
3Y Avg
9.41x
5Y Avg
10.67x
Market Cap
$10.46B
EV/EBITDA Ratio
5.77x
TTM Avg
6.69x
3Y Avg
8.06x
5Y Avg
8.14x
Market Cap
$10.07B
EV/EBITDA Ratio
20.72x
TTM Avg
24.46x
3Y Avg
24.03x
5Y Avg
21.66x
Market Cap
$10.56B
EV/EBITDA Ratio
N/A
TTM Avg
16.32x
3Y Avg
19.19x
5Y Avg
21.31x
Market Cap
$9.94B
EV/EBITDA Ratio
12.51x
TTM Avg
11.70x
3Y Avg
11.93x
5Y Avg
11.67x
Market Cap
$9.93B
EV/EBITDA Ratio
27.74x
TTM Avg
21.80x
3Y Avg
19.72x
5Y Avg
21.58x
Market Cap
$9.92B
EV/EBITDA Ratio
10.20x
TTM Avg
15.14x
3Y Avg
22.02x
5Y Avg
22.95x
Market Cap
$10.79B
EV/EBITDA Ratio
N/A
TTM Avg
13.95x
3Y Avg
19.97x
5Y Avg
24.45x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $10.29B | N/A | N/A | N/A | N/A |
| Molina Healthcare, Inc. (MOH)vs › | $10.45B | 20.31x | 9.46x | 9.41x | 10.67x |
| Universal Health Services, Inc. (UHS)vs › | $10.46B | 5.77x | 6.69x | 8.06x | 8.14x |
| The Ensign Group, Inc. (ENSG)vs › | $10.07B | 20.72x | 24.46x | 24.03x | 21.66x |
| The Cooper Companies, Inc. (COO)vs › | $10.56B | N/A | 16.32x | 19.19x | 21.31x |
| Henry Schein, Inc. (HSIC)vs › | $9.94B | 12.51x | 11.70x | 11.93x | 11.67x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 27.74x | 21.80x | 19.72x | 21.58x |
| Globus Medical, Inc. (GMED)vs › | $9.92B | 10.20x | 15.14x | 22.02x | 22.95x |
| Align Technology, Inc. (ALGN)vs › | $10.79B | N/A | 13.95x | 19.97x | 24.45x |
| Insulet Corp. (PODD)vs › | $9.33B | 15.68x | 30.83x | 46.89x | 87.66x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
